Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives

Abstract Glioblastoma (GBM) is the highest-grade form of glioma, as well as one of the most aggressive types of cancer, exhibiting rapid cellular growth and highly invasive behavior. Despite significant advances in diagnosis and therapy in recent decades, the outcomes for high-grade gliomas (WHO gra...

Full description

Bibliographic Details
Main Authors: Ana Laura V. Alves, Izabela N. F. Gomes, Adriana C. Carloni, Marcela N. Rosa, Luciane S. da Silva, Adriane F. Evangelista, Rui Manuel Reis, Viviane Aline O. Silva
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-021-02231-x
id doaj-812bc95fbdf14b24b09340ead54e478c
record_format Article
spelling doaj-812bc95fbdf14b24b09340ead54e478c2021-03-28T11:09:26ZengBMCStem Cell Research & Therapy1757-65122021-03-0112112210.1186/s13287-021-02231-xRole of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivativesAna Laura V. Alves0Izabela N. F. Gomes1Adriana C. Carloni2Marcela N. Rosa3Luciane S. da Silva4Adriane F. Evangelista5Rui Manuel Reis6Viviane Aline O. Silva7Molecular Oncology Research Center, Barretos Cancer HospitalMolecular Oncology Research Center, Barretos Cancer HospitalMolecular Oncology Research Center, Barretos Cancer HospitalMolecular Oncology Research Center, Barretos Cancer HospitalMolecular Oncology Research Center, Barretos Cancer HospitalMolecular Oncology Research Center, Barretos Cancer HospitalMolecular Oncology Research Center, Barretos Cancer HospitalMolecular Oncology Research Center, Barretos Cancer HospitalAbstract Glioblastoma (GBM) is the highest-grade form of glioma, as well as one of the most aggressive types of cancer, exhibiting rapid cellular growth and highly invasive behavior. Despite significant advances in diagnosis and therapy in recent decades, the outcomes for high-grade gliomas (WHO grades III-IV) remain unfavorable, with a median overall survival time of 15–18 months. The concept of cancer stem cells (CSCs) has emerged and provided new insight into GBM resistance and management. CSCs can self-renew and initiate tumor growth and are also responsible for tumor cell heterogeneity and the induction of systemic immunosuppression. The idea that GBM resistance could be dependent on innate differences in the sensitivity of clonogenic glial stem cells (GSCs) to chemotherapeutic drugs/radiation prompted the scientific community to rethink the understanding of GBM growth and therapies directed at eliminating these cells or modulating their stemness. This review aims to describe major intrinsic and extrinsic mechanisms that mediate chemoradioresistant GSCs and therapies based on antineoplastic agents from natural sources, derivatives, and synthetics used alone or in synergistic combination with conventional treatment. We will also address ongoing clinical trials focused on these promising targets. Although the development of effective therapy for GBM remains a major challenge in molecular oncology, GSC knowledge can offer new directions for a promising future.https://doi.org/10.1186/s13287-021-02231-xChemoradioresistanceClinical trialsGlial stem cellInitiating cellsTherapeutic strategiesNatural products
collection DOAJ
language English
format Article
sources DOAJ
author Ana Laura V. Alves
Izabela N. F. Gomes
Adriana C. Carloni
Marcela N. Rosa
Luciane S. da Silva
Adriane F. Evangelista
Rui Manuel Reis
Viviane Aline O. Silva
spellingShingle Ana Laura V. Alves
Izabela N. F. Gomes
Adriana C. Carloni
Marcela N. Rosa
Luciane S. da Silva
Adriane F. Evangelista
Rui Manuel Reis
Viviane Aline O. Silva
Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
Stem Cell Research & Therapy
Chemoradioresistance
Clinical trials
Glial stem cell
Initiating cells
Therapeutic strategies
Natural products
author_facet Ana Laura V. Alves
Izabela N. F. Gomes
Adriana C. Carloni
Marcela N. Rosa
Luciane S. da Silva
Adriane F. Evangelista
Rui Manuel Reis
Viviane Aline O. Silva
author_sort Ana Laura V. Alves
title Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
title_short Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
title_full Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
title_fullStr Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
title_full_unstemmed Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
title_sort role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
publisher BMC
series Stem Cell Research & Therapy
issn 1757-6512
publishDate 2021-03-01
description Abstract Glioblastoma (GBM) is the highest-grade form of glioma, as well as one of the most aggressive types of cancer, exhibiting rapid cellular growth and highly invasive behavior. Despite significant advances in diagnosis and therapy in recent decades, the outcomes for high-grade gliomas (WHO grades III-IV) remain unfavorable, with a median overall survival time of 15–18 months. The concept of cancer stem cells (CSCs) has emerged and provided new insight into GBM resistance and management. CSCs can self-renew and initiate tumor growth and are also responsible for tumor cell heterogeneity and the induction of systemic immunosuppression. The idea that GBM resistance could be dependent on innate differences in the sensitivity of clonogenic glial stem cells (GSCs) to chemotherapeutic drugs/radiation prompted the scientific community to rethink the understanding of GBM growth and therapies directed at eliminating these cells or modulating their stemness. This review aims to describe major intrinsic and extrinsic mechanisms that mediate chemoradioresistant GSCs and therapies based on antineoplastic agents from natural sources, derivatives, and synthetics used alone or in synergistic combination with conventional treatment. We will also address ongoing clinical trials focused on these promising targets. Although the development of effective therapy for GBM remains a major challenge in molecular oncology, GSC knowledge can offer new directions for a promising future.
topic Chemoradioresistance
Clinical trials
Glial stem cell
Initiating cells
Therapeutic strategies
Natural products
url https://doi.org/10.1186/s13287-021-02231-x
work_keys_str_mv AT analauravalves roleofglioblastomastemcellsincancertherapeuticresistanceaperspectiveonantineoplasticagentsfromnaturalsourcesandchemicalderivatives
AT izabelanfgomes roleofglioblastomastemcellsincancertherapeuticresistanceaperspectiveonantineoplasticagentsfromnaturalsourcesandchemicalderivatives
AT adrianaccarloni roleofglioblastomastemcellsincancertherapeuticresistanceaperspectiveonantineoplasticagentsfromnaturalsourcesandchemicalderivatives
AT marcelanrosa roleofglioblastomastemcellsincancertherapeuticresistanceaperspectiveonantineoplasticagentsfromnaturalsourcesandchemicalderivatives
AT lucianesdasilva roleofglioblastomastemcellsincancertherapeuticresistanceaperspectiveonantineoplasticagentsfromnaturalsourcesandchemicalderivatives
AT adrianefevangelista roleofglioblastomastemcellsincancertherapeuticresistanceaperspectiveonantineoplasticagentsfromnaturalsourcesandchemicalderivatives
AT ruimanuelreis roleofglioblastomastemcellsincancertherapeuticresistanceaperspectiveonantineoplasticagentsfromnaturalsourcesandchemicalderivatives
AT vivianealineosilva roleofglioblastomastemcellsincancertherapeuticresistanceaperspectiveonantineoplasticagentsfromnaturalsourcesandchemicalderivatives
_version_ 1724200387357966336